Search results for " low"

showing 10 items of 972 documents

Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study

2021

Abstract Introduction A hypercoagulable condition was described in patients with coronavirus disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing to disease progression and lethality. Aim We evaluated if in-hospital administration of heparin improved survival in a large cohort of Italian COVID-19 patients. Methods In a retrospective observational study, 2,574 unselected patients hospitalized in 30 clinical centers in Italy from February 19, 2020 to June 5, 2020 with laboratory-confirmed severe acute respiratory syndrome coronavirus-2 infection were analyzed. The primary endpoint in a time-to event analysis was in-hospital death, comparing patients who receive…

Malemedicine.medical_specialtySettore MED/17 - Malattie Infettivecoronavirusheparin030204 cardiovascular system & hematologyLower risklaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineClinical endpointmedicineHumansThrombophilia030212 general & internal medicineHospital MortalityBlood CoagulationSurvival analysisAgedRetrospective Studiestreatmentbusiness.industryHeparinMortality rateCOVID-19mortalityLow-Molecular-WeightAnticoagulantsCOVID-19Retrospective cohort studyHeparinHematologyHeparin Low-Molecular-WeightMiddle AgedmortalitySurvival AnalysisCOVID-19 Drug Treatmentcoagulation activationcoronaviruItalytreatmentsPropensity score matchingcoagulation activation; coronavirus; COVID-19; heparin; mortality; treatmentsFemalecoagulation activation; coronavirus; COVID-19; heparin; mortality; treatments; Aged; Anticoagulants; Blood Coagulation; COVID-19; Female; Heparin; Heparin Low-Molecular-Weight; Hospital Mortality; Humans; Italy; Male; Middle Aged; Retrospective Studies; Survival Analysis; Thrombophiliabusinessmedicine.drug
researchProduct

Spinal cord stimulation: An alternative concept of rehabilitation?

2017

Background: Chronic low back and leg pain is a disabling condition, affecting, in most cases, older patients with congenital or acquired spinal stenosis or patients with failed back surgery syndrome. Spinal cord stimulation has been introduced as an effective therapeutic option for those patients who have previously been operated without significant clinical benefits, or for all those patients who are ineligible for traditional surgery. Methods: We report our experience with ten patients treated with spinal cord stimulation plus medication and physical therapy between November 2014 and September 2015. Inclusion criteria were: previous surgical treatments for lumbar stenosis and metameric in…

Malemedicine.medical_specialtySpinal stenosismedicine.medical_treatmentArthrodesisSpinal cord stimulation03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationSpinal StenosisOlder patientsMedicineHumansFailed Back Surgery SyndromeLow backPhysical Therapy ModalitiesAgedPain MeasurementSpinal Cord StimulationRehabilitationLumbar Vertebraebusiness.industrySettore MED/27 - NeurochirurgiaLeg painMiddle Agedmedicine.diseaseDecompression SurgicalChronic low back painSurgeryBack Pain030220 oncology & carcinogenesisChronic low back painFemalebusiness030217 neurology & neurosurgeryFailed back surgery
researchProduct

Should low high-density lipoprotein cholesterol (HDL-C) be treated?

2014

The first observations linking a low serum level of HDL-C to increased risk for cardiovascular disease were made over 50 years ago. High serum levels of HDL-C appear to protect against the development of atherosclerotic disease, while low serum levels of this lipoprotein are among the most important predictors of atherosclerotic disease in both men and women and people of all racial and ethnic groups throughout the world. It has long been assumed that therapeutic interventions targeted at raising HDL-C levels would lower risk for such cardiovascular events as myocardial infarction, ischemic stroke, and death. Even after five decades of intensive investigation, evidence to support this assum…

Malemedicine.medical_specialtyStatinmedicine.drug_classEndocrinology Diabetes and MetabolismDiseaseLower riskNiacinlaw.inventionCoronary artery diseaseEndocrinologyRandomized controlled triallawRisk FactorsInternal medicinemedicineHumansMyocardial infarctionDyslipidemiasbusiness.industryReverse cholesterol transportCholesterol HDLFibric Acidsmedicine.diseaseEndocrinologyCardiovascular Diseaseslipids (amino acids peptides and proteins)FemaleThiazolidinedionesHydroxymethylglutaryl-CoA Reductase Inhibitorsbusinesscoronary artery disease fibrate high-density lipoproteins low-density lipoproteins niacin reverse cholesterol transport statin thiazolidinedioneNiacin
researchProduct

Effects of Myofascial Release in Nonspecific Chronic Low Back Pain: A Randomized Clinical Trial.

2017

Double-blind, randomized parallel sham-controlled trial with concealed allocation and intention-to treat analysis.To investigate the effects of an isolate myofascial release (MFR) protocol on pain, disability, and fear-avoidance beliefs in patients with chronic low back pain (CLBP).MFR is a form of manual medicine widely used by physiotherapists in the management of different musculoskeletal pathologies. Up to this moment, no previous studies have reported the effects of an isolated MFR treatment in patients with CLBP.Fifty-four participants, with nonspecific CLBP, were randomized to MFR group (n = 27) receiving four sessions of myofascial treatment, each lasting 40 minutes, and to control …

Malemedicine.medical_specialtyTreatment outcomeMEDLINElaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawSurveys and QuestionnairesMedicineHumansOrthopedics and Sports MedicineIn patient030212 general & internal medicinePhysical Therapy ModalitiesAgedbusiness.industryMiddle AgedMyofascial releaseChronic low back painTreatment OutcomePhysical therapyFemaleNeurology (clinical)Chronic PainbusinessLow Back Pain030217 neurology & neurosurgerySpine
researchProduct

Effect of aqueous extract of Ajuga iva supplementation on plasma lipid profile and tissue antioxidant status in rats fed a high-cholesterol diet

2006

Abstract The present study was designed to explore the possible antioxidant and hypolipidemic effects of the aqueous extract of Ajuga iva (0.5% in the diet) in rats fed a high-cholesterol (1%) diet (HCD). The results indicated that the HCD-Ai versus HCD treatment led to many changes in biochemical parameters. They showed a decrease of plasma total cholesterol (TC) and VLDL-cholesterol but an increase of HDL2-cholesterol. The triacylglycerol contents were reduced in plasma and in VLDL. The lipid peroxidation determined by TBARS was decreased by 75% in plasma. TBARS in liver, heart and kidneys were highly reduced excepted in the adipose tissue. Ajuga iva treatment enhanced superoxide dismutas…

Malemedicine.medical_specialtyVery low-density lipoproteinAntioxidantLipoproteinsmedicine.medical_treatmentHypercholesterolemiaAdipose tissueAjugaThiobarbituric Acid Reactive SubstancesAntioxidantsAjugaCholesterol DietaryLipid peroxidationEatingchemistry.chemical_compoundInternal medicineDrug DiscoverymedicineTBARSAnimalsRats WistarPharmacologybiologyPlant ExtractsCholesterolBody WeightOrgan Sizebiology.organism_classificationLipidsDietEnzymesRatsEndocrinologychemistryDietary SupplementsIntestinal cholesterol absorptionlipids (amino acids peptides and proteins)Journal of Ethnopharmacology
researchProduct

Tissue antioxidant status differs in spontaneously hypertensive rats fed fish protein or casein

2003

The present study was designed to determine whether changes in dietary protein source are related to changes in antioxidant status determined by enzyme activities of catalase, superoxide dismutase (SOD), gluthatione peroxidase (GSH-Px) and gluthatione reductase (GSSG-Red) and lipid peroxidation levels in various tissues. Spontaneously hypertensive rats (SHR; 5 wk old) were fed diets containing 20% casein or fish protein for 2 mo. Feeding the fish protein diet lowered blood pressure and reduced plasma total cholesterol levels and SOD activity in all tissues except muscle compared with the casein diet. Feeding fish protein also enhanced GSH level and GSH-Px activity in liver and heart, accomp…

Malemedicine.medical_specialtyVery low-density lipoproteinAntioxidantmedicine.medical_treatmentMedicine (miscellaneous)Blood PressureKidneyFish ProteinsAntioxidantsSuperoxide dismutaseLipid peroxidationchemistry.chemical_compoundRats Inbred SHRCaseinInternal medicineFish ProductsmedicineAnimalsNutrition and DieteticsbiologyCaseinsHeartCatalaseFish productsRatsCholesterolEndocrinologyAdipose TissueLiverchemistryCatalasebiology.proteinDietary ProteinsLipid Peroxidation
researchProduct

Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects.

2010

The first results of the PREDIMED (PREvencion con Dieta MEDiterranea) randomized trial, after 3-month intervention, showed that the Mediterranean Diet (MD), supplemented with either virgin olive oil (VOO) or nuts, reduced systolic blood pressure, serum cholesterol and triacylglycerol (TG) concentrations and increased high-density lipoprotein (HDL)-cholesterol when compared to a control (low-fat diet) group. Serum TG levels are an independent risk factor for coronary heart disease and are strongly determined by very low-density lipoprotein (VLDL) composition, which can be specifically modified by dietary lipid source. Within the context of the PREDIMED study, we assessed the VLDL composition…

Malemedicine.medical_specialtyVery low-density lipoproteinMediterranean dietEndocrinology Diabetes and MetabolismLinoleic acidClinical BiochemistryDietary lipidContext (language use)BiologyLipoproteins VLDLDiet MediterraneanTriacylglycerolBiochemistrychemistry.chemical_compoundBlood serumRisk FactorsMediterranean dietInternal medicineVirgin olive oilmedicineHumansNutsPlant OilsMolecular BiologyOlive OilTriglyceridesAgedNutrition and DieteticsCholesterolMiddle AgedDietary FatsEndocrinologychemistryCardiovascular Diseaseslipids (amino acids peptides and proteins)FemaleVLDLLipoproteinThe Journal of nutritional biochemistry
researchProduct

Hepatic storage and transport of n-3 and n-6 polyunsaturated fatty acids by very-low-density lipoproteins in growing rats fed low- or adequate-protei…

1997

Protein and essential fatty acid (EFA) deficiencies may both occur in chronic malnutrition and have common symptoms. To determine the interactions between dietary protein intake and EFA availability, rats were fed purified diets containing 20% or 2% casein and 5% as one of four fats (sunflower, soybean, coconut, or salmon oil) that differed particularly in their n-6 and n-3 polyunsaturated fatty acids (PUFAs). Protein malnutrition enhanced hepatic triacylglycerol and cholesterol concentrations while decreasing hepatic protein and phospholipid contents and mass and components of very-low-density lipoprotein (VLDL). The ratio of PUFAs to saturated fatty acids (SFAs) was consistently depressed…

Malemedicine.medical_specialtyVery low-density lipoproteinPhospholipidMedicine (miscellaneous)Lipoproteins VLDLBiologydigestive systemchemistry.chemical_compoundDietary Fats UnsaturatedEssential fatty acidFatty Acids Omega-6Protein DeficiencyInternal medicineFatty Acids Omega-3medicineAnimalsFood scienceRats Wistarchemistry.chemical_classificationNutrition and DieteticsCholesterolKwashiorkornutritional and metabolic diseasesfood and beveragesFatty acidmedicine.diseaseDietary FatsRatsApolipoproteinsEndocrinologyLiverchemistryFatty Acids Unsaturatedlipids (amino acids peptides and proteins)Dietary ProteinsLipoproteinPolyunsaturated fatty acidThe American Journal of Clinical Nutrition
researchProduct

Dietary protein deficiency affects n-3 and n-6 polyunsaturated fatty acids hepatic storage and very low density lipoprotein transport in rats on diff…

1994

Fatty livers and the similarity between the skin lesions in kwashiorkor and those described in experimental essential fatty acid (EFA) deficiency have led to the hypothesis that protein and EFA deficiencies may both occur in chronic malnutrition. The relationship between serum very low density lipoprotein (VLDL) and hepatic lipid composition was studied after 28 d of protein depletion to determine the interactions between dietary protein levels and EFA availability. Rats were fed purified diets containing 20 or 2% casein and 5% fat as either soybean oil rich in EFA, or salmon oil rich in eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, or hydrogenated coconut, oil poor in EFA. Animal…

Malemedicine.medical_specialtyVery low-density lipoproteinfood.ingredientLow proteinDocosahexaenoic AcidsBiologyLipoproteins VLDLBiochemistrySoybean oilchemistry.chemical_compoundfoodEssential fatty acidInternal medicineCaseinFatty Acids Omega-6Protein DeficiencyFatty Acids Omega-3medicineAnimalsFood scienceRats WistarPhospholipidsTriglycerideschemistry.chemical_classificationFatty Acids EssentialOrganic Chemistryfood and beveragesFatty acidBiological TransportCell BiologyDietary FatsDietRatsEndocrinologychemistryEicosapentaenoic AcidLiverFatty Acids Unsaturatedlipids (amino acids peptides and proteins)Arachidonic acidDietary ProteinsPolyunsaturated fatty acidLipids
researchProduct

Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats

2007

Rats with carnitine deficiency due to trimethylhydrazinium propionate (mildronate) administered at 80 mg/100 g body weight per day for 10 days developed liver steatosis only upon fasting. This study aimed to determine whether the transient steatosis resulted from triglyceride accumulation due to the amount of fatty acids preserved through impaired fatty acid oxidation and/or from up-regulation of lipid exchange between liver and adipose tissue. In liver, mildronate decreased the carnitine content by approximately 13-fold and, in fasted rats, lowered the palmitate oxidation rate by 50% in the perfused organ, increased 9-fold the triglyceride content, and doubled the hepatic very low density …

Malemedicine.medical_specialtyVery low-density lipoproteintissu adipeuxAdipose tissuerattus rattusBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestéatose hépatiqueCarnitineInternal medicinemedicineAnimalsLipolysisCarnitineRats Wistarpathologie animaleMolecular BiologyBeta oxidationlipide030304 developmental biologychemistry.chemical_classification0303 health sciencesTriglycerideFatty AcidsFatty acidCell Biologyfoiemedicine.diseaseLipidsRats[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry Molecular Biology/Biomolecules [q-bio.BM]Fatty LiverLipoproteins LDLLipoprotein LipaseEndocrinologyAdipose TissueGene Expression RegulationLiverchemistryHepatocytesRATSteatosisTriolein030217 neurology & neurosurgerymedicine.drug
researchProduct